![1]()
News
Smokers with PE have higher rate of hospital readmission
November 11, 2019
NEW ORLEANS – The rate of readmission within 30 days was significantly higher among PE patients with tobacco dependence.
![1]()
News
CDC identifies probable culprit in vaping lung injuries
November 9, 2019
In addition, obtaining vaping devices from informal sources, such as from a dealer, off the street, or from a friend, was more likely to be linked to EVALI.
![1]()
News
Measles infection linked to impaired ‘immune memory’
November 6, 2019
Measles virus infection is associated with significant reductions in pathogen epitopes and antibody reservoirs.
![1]()
News
Vaping-linked lung injury cases near 1,900
October 31, 2019
Thirty-seven deaths from vaping-associated lung injuries have been reported in 24 states and the District of Columbia.
![1]()
News
CDC, FDA in hot pursuit of source of vaping lung injuries
October 29, 2019
Although a definitive cause remains unknown, evidence is accumulating to implicate tetrahydrocannabinol (THC)-containing devices in vaping-related lung injuries.
![1]()
News
THC use reported in majority of vaping-related illnesses
October 28, 2019
“THC-containing products are playing an important role in this outbreak [but] no single compound or ingredient has emerged as the cause.”
![1]()
News
Readmission for COPD exacerbation upped in-hospital mortality risk
October 25, 2019
NEW ORLEANS – Reduction of readmission rates has potential to improve health and economic outcomes, according to researchers.
![1]()
News
Opioids, benzodiazepines carry greater risk of COPD-related hospitalization
October 25, 2019
The risk of hospitalization because of respiratory events for patients with COPD was especially high when opioid and benzodiazepine medications were combined.
![1]()
News
New test edges closer to rapid, accurate ID of active TB
October 23, 2019
The blood-based triage test, which relies upon four host proteins and one TB antigen, is another step closer toward standards proposed by the WHO.
![1]()
News
Vitamin C–based regimens in sepsis plausible, need more data, expert says
October 22, 2019
NEW ORLEANS – Results from the randomized, phase 3 VICTAS study, anticipated in the coming months, may shed light on the clinical role of this adjunctive strategy.
